Nuvation Bio Inc.
NUVB- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001811063
In the last 90 days, Nuvation Bio Inc. insiders filed 0 open-market purchases and 1 sale; 244 institutions reported holding it in 13F filings for Q2 2026, worth $1.33B in total; 3 superinvestors hold it, including Duquesne Family Office and Abrams Capital.
13F holders, Q3 2021
Institutional positions in Nuvation Bio Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 98
- −1 vs. Q2 2021
- Shares held
- 151.3M
- +3.30M (+2.2%) vs. Q2 2021
- Total value
- $1.50B
- +$138.7M (+10.2%) vs. Q2 2021
- New holders
- 15
- 38 more added
- Sold out
- 16
- 22 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NUVB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 244 | $1.33B |
| Q1 2026 | 233 | $947.4M |
| Q4 2025 | 224 | $1.89B |
| Q3 2025 | 203 | $817.8M |
| Q2 2025 | 182 | $439.1M |
| Q1 2025 | 161 | $364.9M |
| Q4 2024 | 160 | $526.0M |
| Q3 2024 | 154 | $428.6M |
| Q2 2024 | 148 | $447.0M |
| Q1 2024 | 124 | $490.1M |
| Q4 2023 | 116 | $202.7M |
| Q3 2023 | 125 | $183.4M |
| Q2 2023 | 124 | $250.2M |
| Q1 2023 | 129 | $228.2M |
| Q4 2022 | 127 | $267.9M |
| Q3 2022 | 122 | $317.5M |
| Q2 2022 | 120 | $503.2M |
| Q1 2022 | 117 | $837.0M |
| Q4 2021 | 105 | $1.32B |
| Q3 2021 | 98 | $1.50B |
| Q2 2021 | 99 | $1.36B |
| Q1 2021 | 73 | $1.48B |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Nuvation Bio Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Marshall Wace, LLP | 0 | $0 | 0.00% | −95,043−100.0% | Sold out |
| Prosight Management, LP | 0 | $0 | 0.00% | −91,694−100.0% | Sold out |
| Maven Securities LTD | 0 | $0 | 0.00% | −40,000−100.0% | Sold out |
| CVI Holdings, LLC | 0 | $0 | 0.00% | −35,056−100.0% | Sold out |
| Exos Asset Management LLC | 0 | $0 | 0.00% | −29,982−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −22,873−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −21,667−100.0% | Sold out |
| Davenport & Co LLC | 0 | $0 | 0.00% | −16,000−100.0% | Sold out |
| Wetherby Asset Management Inc | 0 | $0 | 0.00% | −12,385−100.0% | Sold out |
| Pearl River Capital, LLC | 0 | $0 | 0.00% | −11,441−100.0% | Sold out |
| HSBC Holdings PLC | 0 | $0 | 0.00% | −10,587−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −4,495−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −27−100.0% | Sold out |